Concepedia

Amineh Ghaderi

AG

Statistics

Publications

6

Citations

142

H-Index

6

Active since

2018

Affiliations

Karolinska Institutet(Current)

Kancera (Sweden)

Karolinska University Hospital

Amineh Ghaderi is an author at Karolinska Institutet specializing in oncology, apoptosis in cancer, and molecular oncology.

Publications per year

2018–2023

6

Publications

6

A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib

Amir Hossein Daneshmanesh, Mohammad Hojjat‐Farsangi, Amineh Ghaderi et al. · PLoS ONE · 2018 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells

Amineh Ghaderi, Amir Hossein Daneshmanesh, Ali Moshfegh et al. · Biomedicines · 2020 · 38 citations · Full text

Medicine, Hematology, Oncology +14

A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells

Amineh Ghaderi, Wen Zhong, Mohammad Ali Okhovat et al. · Pharmaceutics · 2022 · 19 citations · Full text

Medicine, Cancer Biology, Oncology +17

Rational Nanotoolbox with Theranostic Potential for Medicated Pro‐Regenerative Corneal Implants

Hirak K. Patra, Mohammad Azharuddin, Mohammad Mirazul Islam et al. · Advanced Functional Materials · 2019 · 16 citations · Full text

Engineering, Bioengineering, Biotechnology +17

A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells

Amineh Ghaderi, Mohammad Ali Okhovat, Jemina Lehto et al. · Pharmaceutics · 2023 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 6